Lake Street Downgrades Surmodics to Hold, Announces $43 Price Target
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Brooks O'Neil has downgraded Surmodics (NASDAQ:SRDX) from Buy to Hold and set a price target of $43.

May 29, 2024 | 7:57 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Lake Street analyst Brooks O'Neil downgraded Surmodics from Buy to Hold and set a price target of $43.
The downgrade from Buy to Hold by a reputable analyst and the setting of a price target at $43, which may be below current market expectations, is likely to negatively impact investor sentiment and short-term stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100